Evidentic6 [Evidentic] Adalimumab [Evidentic] Adalimumab BATCH NUMBER: 70225XH07 Product specifications: Quality Standard clinical grade Product Concentration100 mg/mL Volume per vial 40 µL Quantity per vial 4 mg Batch Number 70225XH07 Storage Temperature -80°C Original therapeutic expiry date:09/2018 Our products are for research use only. The “therapeutic expiration date” implies expiry date for patient adminstration and is n.. 2023. 4. 27. [Evidentic] Alemtuzumab [Evidentic] Alemtuzumab BATCH NUMBER: BW1652 Product specifications: Quality Standardclinical grade Product Concentration10 mg/mL Volume per vial50 µL Quantity per vial0,5 mg Batch NumberBW1652 Storage Temperature-80°C Original therapeutic expiry date:08/2022 Our products are for research use only. The “therapeutic expiration date” implies expiry date for patient adminstration and is not applic.. 2022. 9. 26. [Evidentic] Bevacizumab [Evidentic] Bevacizumab BATCH NUMBER: B7226H07 Product specifications: Quality Standardclinical grade Product Concentration25 mg/mL Volume per vial80 µL Quantity per vial2 mg Batch NumberB7226H07 Storage Temperature-80°C Original therapeutic expiry date:12/2018 Our products are for research use only. The “therapeutic expiration date” implies expiry date for patient adminstration and is not appl.. 2022. 8. 16. [Evidentic] Adalimumab [Evidentic] Adalimumab BATCH NUMBER: 76287XH11 Target TNF alpha Class of molecule Monoclonal Antibody Isotype IgG1 - Fully human Host cells Chinese Hamster Ovary (CHO) cells Prepared from (Reference drug) Humira® Therapeutic Area Auto-immune diseases Therapeutic Indications Ankylosing Spondylitis, Crohn's Disease, Juvenile rheumatoid arthritis, Psoriasis, Psoriatic Arthritis, Ulcerative colitis.. 2022. 5. 25. [Evidentic] Adalimumab [Evidentic] Adalimumab BATCH NUMBER: 73254XH03 Target TNF alpha Class of molecule Monoclonal Antibody Isotype IgG1 - Fully human Host cells Chinese Hamster Ovary (CHO) cells Prepared from (Reference drug) Humira® Therapeutic Area Auto-immune diseases Therapeutic Indications Ankylosing Spondylitis, Crohn's Disease, Juvenile rheumatoid arthritis, Psoriasis, Psoriatic Arthritis, Ulcerative colitis.. 2022. 4. 25. [Evidentic] Daratumumab [Evidentic] Daratumumab GHS0702 Product Concentration 20 mg/mL Volume per vial 100 µL Quantity per vial 2 mg Batch Number GHS0702 Storage Temperature -80°C Target CD38 Class of molecule Monoclonal Antibody Isotype IgG1 kappa - Fully human Host cells Chinese Hamster Ovary (CHO) cells Prepared from (Reference drug) Darzalex® Therapeutic Area Immuno-oncology Therapeutic Indications Multiple Myelom.. 2021. 10. 14. 이전 1 다음
